SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FLXN, AZPN, COLB, LMRK; Shareholders are Encouraged to Contact the Firm

NEW YORK, Oct. 20, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Flexion Therapeutics, Inc. (NASDAQ: FLXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Pacira BioSciences, Inc. for $8.50 per share in cash plus one non-tradeable contingent value right worth up to $8.00 per share in cash. If you are a Flexion shareholder, click here to learn more about your rights and options.